Literature DB >> 6856248

The classification of retinal detachment with proliferative vitreoretinopathy.

.   

Abstract

The term proliferative vitreoretinopathy (PVR) is proposed as a designation for the clinical condition previously known variously as massive vitreous retraction, massive preretinal retraction, or massive periretinal proliferation. This is an abnormality in which rhegmatogenous retinal detachment is complicated by proliferation of membranes on both surfaces of the detached retina and on the posterior surface of the detached vitreous gel. The new classification subdivides PVR into four stages: A, minimal; B, moderate; C, marked; and D, massive. The extent of the fixed retinal folds is subdivided to indicate the number of involved quadrants. The degree of retinal shrinkage into a funnel-like configuration is subdivided into three grades.

Entities:  

Mesh:

Year:  1983        PMID: 6856248     DOI: 10.1016/s0161-6420(83)34588-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  127 in total

1.  Retinal detachment surgery in district general hospitals: an audit of changing practice.

Authors:  R Ling; C James; P Simcock; R Gray; S Shaw
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

2.  Conventional buckling surgery or primary vitrectomy with silicone oil tamponade in rhegmatogenous retinal detachment with multiple breaks.

Authors:  Filiz Afrashi; Tansu Erakgun; Cezmi Akkin; Mahmut Kaskaloglu; Jale Mentes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-09       Impact factor: 3.117

3.  Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Eudoxia Diza; Eleni Papakonstantinou; Efimia Souliou; George Karakiulakis; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

4.  Vitrectomy with and without scleral buckle for inferior retinal detachment.

Authors:  Y Y Y Kwong; C W Tsang; W W Lai; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

5.  A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting; Andrea Vento; Federica Cresti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

6.  Indocyanine green-assisted peeling of the epiretinal membrane in proliferative vitreoretinopathy.

Authors:  Hidehisa Sakamoto; Ichiro Yamanaka; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-20       Impact factor: 3.117

Review 7.  Retinal detachment.

Authors:  David Steel
Journal:  BMJ Clin Evid       Date:  2014-03-03

8.  Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.

Authors:  C Symeonidis; S Androudi; I Georgalas; A Tzamalis; N Chalvatzis; T Rotsos; E Souliou; E Diza; S A Dimitrakos
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

9.  Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study.

Authors:  S Binder; M Bonnet; M Velikay; J P Gerard; U Stolba; A Wedrich; H Hohenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

10.  Preoperative duration of retinal detachment and subretinal immunoreactive endothelin-1: repercussion on logarithmic visual acuity.

Authors:  Manuela Roldán-Pallarès; Abdalla-Sadiq Musa; Carmen Bravo-Llatas; Raquel Fernández-Durango
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.